Image Commercially Licensed From: Unsplash

In examining diabetic amputation statistics, it becomes apparent that 13 percent of adults in the United States grapple with diabetes, while an additional 2.8 percent live with undiagnosed diabetes, totaling approximately 15 percent or 41.5 million adults. These individuals are advised not to be disheartened by the prevalence of diabetic amputation statistics, as there exist proactive measures to avert diabetes-related complications jeopardizing limb health.

A critical facet of this preventative effort involves understanding the interconnection between Peripheral Artery Disease (PAD) and diabetic amputation statistics. The symbiotic relationship between diabetes and PAD arises from diabetes’ impact on blood sugar control, characterized by elevated blood sugar, heightened cholesterol, and insulin resistance. These factors contribute to arterial damage, fostering plaque accumulation on artery walls.

Concerned about PAD? Unaware of its symptoms? Then you should consult with adept vascular doctors and surgeons specialize in diagnosing and treating Peripheral Artery Disease. Their compassionate approach aims to shield individuals from becoming statistics in diabetic amputations.

The assurance of optimal care is extended across wound care centers nationwide. Those seeking to learn more about PAD treatment and prevent diabetic amputation statistics are encouraged to schedule an appointment. Annually in the United States, approximately 154,000 with diabetes undergo amputations each year, while about 73,000 non-trauma-related lower limb amputations are performed. The average cost for each amputation is over $70,000.

Here are 15 distinctive statistics pertaining to PAD and diabetic amputations, pertinent for individuals with diabetes or those suspecting diabetes and PAD:

1. Over 80% of diabetic amputations originate from foot ulcers.
2. Around 15% of diabetes patients concurrently experience a foot ulcer.
3. Of this 15%, approximately 6% face hospitalization due to foot ulcer complications.
4. Diabetes stands as the foremost cause of non-traumatic lower-limb amputation in the United States.
5. Peripheral artery disease impacts 8 to 10 million individuals in the United States.
6. Among these individuals, 11% develop Critical Limb Ischemia (CLI), marked by severe limb pain, non-healing wounds, and gangrene.
7. 25% of Critical Limb Ischemia patients necessitate life-saving limb amputation within a year of diagnosis.
8. Approximately 20% of amputee patients face mortality within a year post-PAD or diabetes-related minor lower extremity amputation, with 44.1% facing mortality within 5 years.
9. The survival rate following a major lower extremity amputation is only about 40% within 5 years, resulting in a 60% mortality rate.
10. Merely 37% of patients regain pre-amputation mobility.
11.  Approximately 75% of diabetic foot ulcers are deemed preventable.
12. Enhanced awareness of PAD could potentially lower PAD and diabetes-related ulcer rates.
13. Primary care physicians exhibit only a 50% awareness of patient PAD history.
14. Only 26% of individuals aged 50 or older are cognizant of PAD’s existence.
15. Roughly 30% of diabetes patients regularly receive foot care to monitor for ulcers.

While these diabetic amputation statistics may raise concerns, heightened awareness of PAD and diabetes can significantly mitigate foot ulcers and amputations. Recognizing early signs of restricted blood flow is pivotal in preventing diabetes and PAD amputation statistics.

Contributing Factors to Diabetic Wounds

Factors contributing to foot ulcers significantly escalating amputation risk include peripheral artery disease, a sedentary lifestyle, smoking, high blood glucose levels, prolonged diabetes history (10+ years), hypertension, diabetic neuropathy, and nerve damage leading to loss of sensation in legs and feet. Routine foot examinations can aid in early ulcer detection, thus averting diabetic amputation statistics.

Risk Factors to Know About

Individuals with a history of diabetic foot ulcers or those above 40 are at an elevated risk. Understanding these risk factors empowers individuals to monitor their health, circumventing diabetic amputation statistics.

Overlapping risk factors for developing diabetic foot ulcers and PAD foot ulcers include diabetes, smoking, sedentary lifestyle, high cholesterol, high blood pressure, obesity, and age over 60, escalating the risk of PAD ulcers and potential amputation if unaddressed.

Steps to Reduce Getting Diabetic Ulcers

To enhance leg circulation and sidestep amputation, lifestyle changes such as smoking cessation, initiating an exercise regimen, daily foot care, diabetes management, and medication to control blood sugar, blood pressure, or cholesterol are recommended. These measures are instrumental in thwarting daunting diabetic amputation statistics.

Individuals detecting early signs of PAD, such as numbness, tingling, coldness, changes in skin color, lower extremity edema, slowed hair or toenail growth, or advanced signs like leg pain while exercising, slow-healing wounds, or foot ulcers, should promptly seek evaluation from a vascular doctor. Improved leg circulation emerges as one of the most effective strategies in preventing or treating PAD and diabetic foot ulcers.

Considering Vitastem Ultra for Healing Diabetic Wounds

Vitastem Ultra is an FDA-registered topical antibiotic spray and one of the strongest first aid & wound care treatments for infection prevention available for over the counter (OTC) use in the world. Vitastem is a multi-use topical antibiotic that is best used for treating diabetic ulcers, along with acne, first to third-degree burns, cuts & scrapes, eczema, psoriasis, lacerations, scars, shingles, staph, MRSA, and other minor to severe wounds like no other antibiotic available to consumers in the market.

Vitastem Ultra is the only antibiotic in the world that kills with both a physical and chemical mechanism, giving it a unique ability to defeat drug resistant bacteria. This miracle worker possesses a unique ability to heal and regenerate tissue unlike any other medication available on the market.

Vitastem Ultra boasts 96% of patients with diabetic wounds & ulcers see improvement within just 2 weeks, dwarfing the largest name brand Rx competitor at 50% of patients seeing improvements at 20 weeks. To date, Vitastem has saved countless patients from amputations thus reducing their hospital stays and increasing their life expectancy.

About every 3 minutes and 30 seconds in the United States, a limb is amputated due to diabetes. So, if you or a loved one is suffering from a non-healing diabetic wound or has recently been diagnosed with one, then make sure to ask your doctor if Vitastem can be a good solution for treating diabetic ulcers, so you can heal faster, reduce lengthy hospital stays, increase mobility, and get back to living your life to the fullest once again.